Skip to main content
Explore URMC
menu

Angela R. Girvin, M.D.

Contact Information

Phone Numbers

Appointment: (585) 276-3000

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Patient Care Setting

Pediatrics

Biography

I am most interested in the treatment and care of children with leukemia/lymphoma and rare tumors as well as children with blood diseases.

Research

I am interested in improving the care provided to families with cancer and blood disorders through quality improvement research.

Credentials

Specialties

  • Pediatrics - American Board of Pediatrics
  • Pediatric Hematology-Oncology - American Board of Pediatrics

Education

2010
MD | School of Medicine & Biomedical Sciences - State University of New York at Buffalo

Post-doctoral Training & Residency

07/01/2013 - 06/30/2016
Fellowship in Pediatric Hematology/Oncology at Children's Hospital of Pittsburgh

07/01/2011 - 06/30/2013
Residency in Pediatrics at Children's Hospital of Pittsburgh

07/01/2010 - 06/30/2011
Internship in Pediatrics at Children's Hospital of Pittsburgh

VIEW ALL expand_more

Awards

2019 - 2019
RISE to the Top Scholar
Location: University of Rochester

2015 - 2015
CureRock Trainee Research Award

2010 - 2010
Alpha Omega Alpha

2006 - 2006
Beta Beta Beta National Biological Honor Society

2003 - 2003
Delta Epsilon Sigma National Catholic University Honor Society

2003 - 2003
Sigma Alpha Sigma

VIEW ALL expand_more

Clinical Trials

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Tumors Harboring Activating MAPK Pathway Mutations,NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Tumors Harboring Activating MAPK Pathway Mutations

Lead Researcher: Angela R Girvin

This phase II Pediatric MATCH trial studies how well selumetinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with MAPK pathway activation mutations that have spread to other places in the body and have come back or do not respond to treatment. Selumetinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

View Study Details

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years

Lead Researcher: Angela R Girvin

This partially randomized phase III trial is studying maintenance chemotherapy to see how well it works compared to observation following induction chemotherapy and radiation therapy in treating young patients with newly diagnosed ependymoma. Drugs used in chemotherapy, such as vincristine sulfate, carboplatin, cyclophosphamide, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Giving chemotherapy with radiation therapy may kill more tumor cells and allow doctors to save the part of the body where the cancer started.

View Study Details

Publications

Journal Articles

5/18/2021
Fries C, Girvin AR, Korones DN, Weintraub L, Fitzpatrick L, Andolina JR. "Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children." Journal of pediatric hematology/oncology.. 2021 May 18; Epub 2021 May 18.

8/2018
Andolina JR, Reinish AL, Akhtar R, Noronha S, Shand JC, Girvin A, Korones DN, Bruckner LB, Mullen CA, Curran KJ, Boulad F. "Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children." Pediatric blood & cancer.. 2018 Aug 0; 65(8):e27218. Epub 2018 May 03.

6/2009
Steiner WW, Steiner EM, Girvin AR, Plewik LE. "Novel nucleotide sequence motifs that produce hotspots of meiotic recombination in Schizosaccharomyces pombe." Genetics.. 2009 Jun 0; 182(2):459-69. Epub 2009 Apr 10.

VIEW ALL PUBLICATIONS